A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.

Tubulis has completed a Series C, securing €308m ($361m) to be directed towards advancing clinical development of its ADC ...

With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ...

Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for 200m yuan ($28m).

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...

Goldman Sachs has secured the top spot as the leading financial adviser in mergers and acquisitions (M&A) based on deal value ...

Kirkland & Ellis has secured the foremost position as a legal adviser in the mergers and acquisitions (M&A) sector in terms ...

BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...

Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

Pfizer's Tukysa could become the first update to the maintenance regimen for HER2-positive breast cancer in over a decade if ...

A spike in licensing of candidates developed in China this year is a sign of the country’s transition in the global pharma ...

Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...